In this episode, we're joined by Andrea Gooding, Specialty General Manager for Cellular Pathology at Nottingham University Hospitals, and our very own Anthony Johnson, UK Sales Manager. Delve into the world of pathology and histology from the early 2000s, highlighting the pivotal role of pathology labs in therapeutics and patient care. Uncover the significant advancements that have transformed the field and the contemporary challenges in managing turnaround times, team dynamics, and clinical demands. Our guests share their personal tales and insights from their journey in this constantly evolving industry. Tune in for an engaging discussion that traverses the past, present, and future of pathology and histology.
In this episode, we explore Diagnexia's client onboarding process, offering valuable insights for both internal teams and potential clients. We discuss the need for outsourced services, client engagement strategies, and interactions with key stakeholders. The conversation covers framework agreements, legal requirements, data security, and ongoing customer service. We also delve into the integration and validation of pathologists, platform improvements, and the use of automation for case tracking. The episode concludes with a discussion on Diagnexia's unique offerings and its vision for expanding service provision in the UK and globally.
Diagnexia is an international Pathology Services company with facilities in Chicago, Dublin and Exeter UK. Its’ mission is to improve patient experience by improving turnaround time for diagnoses. It helps hospitals balance case workload & remove backlogs by connecting them to a Global Virtual Pathology team via the Diagnexia platform. Keith Kaplan is the host of this podcast. Kaplan is a Pathologist and Laboratory Medical Director at Alliances Pathology Consultants Ltd., as well as a Publisher at tissuepathology.com. Our guests on this podcast include Bob McGonnagle, Publisher at Publisher at College of American Pathologists (CAP), and Moira Larsen, Physician Executive Director of MedStar Medical Group Pathology at MedStar Health.
Dr Donal O’Shea is the Founder & Chief Executive Officer He is an experienced industry leader in the technology and diagnostics sectors. He has founded three technology and imaging companies and has senior management experience with Genetix, Leica Microsystems and Leica Biosystems. Also joining us on our first episode is Steve Blunden Cellular and Anatomical Pathology Operations Manager at University Hospitals Plymouth NHS Trust.